Previous 10 | Next 10 |
2023-12-04 10:02:05 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble For further details see: Ocular Therapeutix, EyePoint Pharmaceuticals among healthcare movers
SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Company will participate at the Centers for Medicare & Medicaid...
Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial...
2023-11-01 13:38:15 ET Gainers: Patriot Transportation Holding ( PATI ) +103% . Aldeyra Therapeutics ( ALDX ) +50% . Davis Commodities Ltd. ( DTCK ) +33% . TG Therapeutics ( TGTX ) +32% . Silence Therapeutics ( SLN ) +31% . S...
2023-10-26 18:23:07 ET Ekso Bionics Holdings, Inc. (EKSO) Q3 2023 Earnings Call October 26, 2023 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Scott Davis - Chief Executive Officer Jason Jones - Chief Operating Officer Jerome Wong - Chie...
2023-10-26 16:12:03 ET Ekso Bionics Holdings press release ( NASDAQ: EKSO ): Q3 GAAP EPS of -$0.24. Revenue of $4.6M (+39.4% Y/Y). Sold a total of 41 EksoHealth devices in the third quarter of 2023. For further details see: Ekso Bionics Holdings GAAP EPS of -...
SAN RAFAEL, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended September 30, 2023. ...
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Ekso Bionics Holdings Inc. (EKSO) is expected to report $-0.31 for Q3 2023
2023-10-25 17:35:57 ET More on Ekso Bionics Holdings Ekso Bionics Holdings, Inc. (EKSO) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Ekso Bionics Holdings Historical earnings data for Ekso Bionics Holdings Financial information for ...
News, Short Squeeze, Breakout and More Instantly...
Ekso Bionics Holdings Inc. Company Name:
EKSO Stock Symbol:
NASDAQ Market:
Collaboration Expands Use of EksoNR and Ekso Indego Devices in Rehabilitation and Community Settings to Better Improve Patient Quality of Life SAN RAFAEL, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso...
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer Scher SAN RAFAEL, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”...
Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ET SAN RAFAEL, Calif., May 10, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical ...